Coronary artery diseasePub Date : 2026-12-01Epub Date: 2026-04-30DOI: 10.1097/MCA.0000000000001648
Ricardo F O Suruagy-Motta, Julia Tirelli-Rocha, Luiz Guilherme Silva Almeida, Ana Beatriz P Aguiar-Barros, Lucas Lima Mendes, Leonardo Dexheimer da Silva, Kalgi Modi, Pedro Cox-Alomar, Pedro Henrique Magalhães Craveiro de Melo, Evandro Martins Filho, Alexandre Abizaid, Brunna Pileggi
{"title":"Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: a systematic review and meta-analysis.","authors":"Ricardo F O Suruagy-Motta, Julia Tirelli-Rocha, Luiz Guilherme Silva Almeida, Ana Beatriz P Aguiar-Barros, Lucas Lima Mendes, Leonardo Dexheimer da Silva, Kalgi Modi, Pedro Cox-Alomar, Pedro Henrique Magalhães Craveiro de Melo, Evandro Martins Filho, Alexandre Abizaid, Brunna Pileggi","doi":"10.1097/MCA.0000000000001648","DOIUrl":"10.1097/MCA.0000000000001648","url":null,"abstract":"<p><strong>Background: </strong>The optimal duration of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention for coronary bifurcation lesions remains uncertain. This meta-analysis focused on comparing ischemic and bleeding outcomes between short-term (≤6 months) and long-term (>6 months) DAPT in this high-risk subgroup.</p><p><strong>Methods: </strong>We included six studies comprising 12 066 patients with bifurcation lesions treated with drug-eluting stents and either short- or long-term DAPT. Pooled relative risk (RR) and 95% confidence intervals (CI) were calculated for major adverse cardiovascular events (MACE), all-cause and cardiac mortality, myocardial infarction, stent thrombosis, stroke, bleeding, and target lesion revascularization.</p><p><strong>Results: </strong>Short-term DAPT was associated with significantly higher risks of MACE (RR 1.79; 95% CI 1.05-3.07), all-cause mortality (RR: 2.78; 95% CI: 1.49-5.19), cardiac death (RR 2.29; 95% CI 1.34-3.91), and stent thrombosis (RR: 4.90; 95% CI: 2.78-8.66). Although the risks of myocardial infarction (RR: 1.75; 95% CI: 0.69-4.47), stroke (RR: 1.07; 95% CI: 0.61-1.67), bleeding (RR: 1.49; 95% CI: 0.24-9.48), and target lesion revascularization (RR: 1.35; 95% CI: 0.85-2.12) did not reach statistical significance, the effect estimates consistently favored long-term DAPT.</p><p><strong>Conclusion: </strong>In patients undergoing percutaneous coronary intervention for bifurcation lesions, short-term DAPT was associated with significantly worse ischemic outcomes, including increased rates of MACE, death, and stent thrombosis. These findings support the use of extended DAPT duration as the preferred strategy in this anatomical subgroup, with treatment tailored according to individual bleeding risk.</p>","PeriodicalId":10702,"journal":{"name":"Coronary artery disease","volume":" ","pages":"571-579"},"PeriodicalIF":2.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147764854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coronary artery diseasePub Date : 2026-12-01Epub Date: 2026-07-07DOI: 10.1097/MCA.0000000000001660
Hack-Lyoung Kim, Yoonjong Bae, Mina Kim, Haechan Cho, Hyun Sung Joh, Woo-Hyun Lim, Jae-Bin Seo, Sang-Hyun Kim, Myung-A Kim
{"title":"Sex differences of clinical outcomes in patients undergoing percutaneous coronary intervention: a nationwide cohort study.","authors":"Hack-Lyoung Kim, Yoonjong Bae, Mina Kim, Haechan Cho, Hyun Sung Joh, Woo-Hyun Lim, Jae-Bin Seo, Sang-Hyun Kim, Myung-A Kim","doi":"10.1097/MCA.0000000000001660","DOIUrl":"10.1097/MCA.0000000000001660","url":null,"abstract":"<p><strong>Background: </strong>Sex differences in outcomes after percutaneous coronary intervention (PCI) remain debated, and evidence from large Asian populations is limited.</p><p><strong>Methods: </strong>We analyzed 136 109 patients (101 301 men; 34 808 women) without prior major cardiovascular events who underwent PCI between 2004 and 2020, using data from the Korean National Health Insurance Service. Baseline characteristics, in-hospital events, and long-term clinical outcomes were compared. The primary endpoint was major adverse cardiovascular events (MACE), defined as a composite of all-cause death, nonfatal myocardial infarction, repeat PCI, coronary artery bypass surgery, and ischemic stroke.</p><p><strong>Results: </strong>Women were older and had higher rates of hypertension and diabetes, whereas men had higher smoking and alcohol consumption rates. In-hospital adverse events, including death, ischemic stroke, and bleeding were more frequent in women ( P < 0.001). However, during a mean follow-up of 3.1 years, women had a lower incidence of MACE compared to men (58.0 vs. 65.3%; P < 0.001). Multivariable Cox regression confirmed that female sex was independently associated with a lower long-term risk of MACE (adjusted hazard ratio: 0.69-0.82, P < 0.001).</p><p><strong>Conclusion: </strong>Despite worse in-hospital outcomes, women had a more favorable long-term prognosis after PCI compared to men. These findings emphasize the importance of sex-specific approaches in risk assessment and long-term management after PCI.</p>","PeriodicalId":10702,"journal":{"name":"Coronary artery disease","volume":" ","pages":"617-624"},"PeriodicalIF":2.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148396405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coronary artery diseasePub Date : 2026-12-01Epub Date: 2026-07-10DOI: 10.1097/MCA.0000000000001661
Tim Heller, Peter Ong, Udo Sechtem, Raffi Bekeredjian
{"title":"Management of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patients.","authors":"Tim Heller, Peter Ong, Udo Sechtem, Raffi Bekeredjian","doi":"10.1097/MCA.0000000000001661","DOIUrl":"10.1097/MCA.0000000000001661","url":null,"abstract":"<p><p>Primary percutaneous coronary intervention (PCI) of the culprit lesion is the preferred treatment in ST-segment elevation myocardial infarction (STEMI). However, in nearly half of all patients, multivessel coronary artery disease is present, raising fundamental questions: should non-culprit lesions be treated at all, and if so, should revascularization be performed immediately or in a staged fashion? Furthermore, should lesion selection be guided by angiography or by functional and imaging-based assessment? Over the past decade, landmark trials shifted clinical practice and formed the basis for current guideline recommendations of the European Society of Cardiology, advocating routine complete revascularization within 45 days in all hemodynamically stable patients. Yet, recently published evidence has challenged this paradigm. New randomized trials exploring the timing and guidance of non-culprit lesion PCI have yielded heterogeneous and, at times, conflicting results. While some suggest that immediate complete revascularization is safe, others raise concerns in patients with impaired cardiac function. Another recently published trial introduces a novel concept by directly comparing immediate physiology-guided PCI with a staged, noninvasive ischemia-guided strategy, demonstrating similar long-term outcomes with substantially fewer interventions. Together, these findings are reshaping the current view of the management of multivessel disease in STEMI. The metaphoric 'therapeutic pendulum' - after swinging firmly towards immediate complete revascularization - is beginning to swing back towards a more individualized, physiology- and imaging-based approach. The central aim of this review is to evaluate whether this individualized staged physiology- and imaging-based approach is a valid alternative to immediate complete revascularization. Clarifying which patients truly benefit from immediate complete revascularization remains a pivotal challenge for future clinical research and guideline development.</p>","PeriodicalId":10702,"journal":{"name":"Coronary artery disease","volume":" ","pages":"625-633"},"PeriodicalIF":2.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148410945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coronary artery diseasePub Date : 2026-12-01Epub Date: 2026-10-28DOI: 10.1097/MCA.0000000000001633
Zhenzhen Xiao, Xiaojing Ma, Li Zhu
{"title":"Long-term evolution of a 5-cm giant right coronary artery-to-left ventricular fistula: a 6-year clinical follow-up.","authors":"Zhenzhen Xiao, Xiaojing Ma, Li Zhu","doi":"10.1097/MCA.0000000000001633","DOIUrl":"10.1097/MCA.0000000000001633","url":null,"abstract":"","PeriodicalId":10702,"journal":{"name":"Coronary artery disease","volume":" ","pages":"641-642"},"PeriodicalIF":2.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147497764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coronary artery diseasePub Date : 2026-12-01Epub Date: 2026-02-18DOI: 10.1097/MCA.0000000000001624
Mehmet Kamil Teber, Mustafa Gök, Mehmet Zafer Aydın, Ziya Şimşek
{"title":"Successful percutaneous retrieval of a fully deployed right coronary artery stent using a snare device: a rare and complication-free case.","authors":"Mehmet Kamil Teber, Mustafa Gök, Mehmet Zafer Aydın, Ziya Şimşek","doi":"10.1097/MCA.0000000000001624","DOIUrl":"10.1097/MCA.0000000000001624","url":null,"abstract":"","PeriodicalId":10702,"journal":{"name":"Coronary artery disease","volume":" ","pages":"637-638"},"PeriodicalIF":2.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146218936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coronary artery diseasePub Date : 2026-12-01Epub Date: 2026-10-28DOI: 10.1097/MCA.0000000000001630
Mustafa Tunahan Öz, Revan Israfilov, Umut Şahin, Adnan Kaya
{"title":"Comment on 'Mechanistic insights into lumen reduction after implantation of a drug-eluting bioresorbable metallic scaffold assessed with serial intracoronary imaging: from the OPTIMIS trial'.","authors":"Mustafa Tunahan Öz, Revan Israfilov, Umut Şahin, Adnan Kaya","doi":"10.1097/MCA.0000000000001630","DOIUrl":"10.1097/MCA.0000000000001630","url":null,"abstract":"","PeriodicalId":10702,"journal":{"name":"Coronary artery disease","volume":" ","pages":"650-651"},"PeriodicalIF":2.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147347474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coronary artery diseasePub Date : 2026-12-01Epub Date: 2026-06-09DOI: 10.1097/MCA.0000000000001657
Byoung Geol Choi, Ji-Yeon Hong, Seung-Woon Rha, Seung Uk Lee, Myung Ho Jeong, Dong Joo Oh
{"title":"De-escalation from prasugrel to clopidogrel at the 12-month landmark after percutaneous coronary intervention with drug-eluting stents for acute myocardial infarction: a Korea Acute Myocardial Infarction Registry-National Institutes of Health cohort study.","authors":"Byoung Geol Choi, Ji-Yeon Hong, Seung-Woon Rha, Seung Uk Lee, Myung Ho Jeong, Dong Joo Oh","doi":"10.1097/MCA.0000000000001657","DOIUrl":"10.1097/MCA.0000000000001657","url":null,"abstract":"<p><strong>Background: </strong>Guidelines recommend 12 months of potent P2Y12 inhibitor-based dual antiplatelet therapy after acute myocardial infarction-drug-eluting stents (AMI-DES) percutaneous coronary intervention, but the optimal strategy beyond 1 year remains unclear. We evaluated the clinical impact of de-escalating from prasugrel to clopidogrel at the 12-month landmark.</p><p><strong>Methods: </strong>Using the nationwide Korea Acute Myocardial Infarction Registry-National Institutes of Health registry, we identified AMI patients who underwent successful percutaneous coronary intervention with DES and remained event free on aspirin-prasugrel (ASA/PSG) for 12 months. Patients were categorized into those who continued ASA/PSG or de-escalated to aspirin-clopidogrel (ASA/CPG). The primary endpoint was a composite of cardiovascular death, nonfatal myocardial infarction, or stroke during months 12-24. Propensity score matching was used to adjust for confounders.</p><p><strong>Results: </strong>Among 967 eligible patients, 384 continued ASA/PSG and 304 de-escalated to ASA/CPG. In the unmatched cohort, the cumulative incidence of the primary endpoint was lower in the ASA/CPG group (log-rank P = 0.045). In the propensity score matching cohort (250 pairs), there were no significant differences between the ASA/CPG and ASA/PSG groups for the primary endpoint ( P = 0.316) or the secondary composite ( P = 0.378). Absolute event rates were notably low in both groups; specifically, no definite/probable stent thrombosis or major bleeding occurred during the second year. Propensity score-adjusted Cox models confirmed these neutral findings (hazard ratio: 1.06, 95% confidence interval: 0.52-2.12).</p><p><strong>Conclusion: </strong>In stabilized AMI-DES survivors, de-escalating to clopidogrel at 12 months showed no significant difference in observed clinical outcomes compared with continued prasugrel, alongside a favorable safety profile. These findings suggest that clopidogrel-based de-escalation may be a reasonable step-down strategy in the second year, aligning with personalized therapy recommendations.</p>","PeriodicalId":10702,"journal":{"name":"Coronary artery disease","volume":" ","pages":"597-605"},"PeriodicalIF":2.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148197635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}